← Back to Clinical Trials
Recruiting NCT06060639

NCT06060639 Variation of Echocardiographic Parameters After Red Blood Cell Transfusion in Emergency Department Anemic Patients

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06060639
Status Recruiting
Phase
Sponsor Centre Hospitalier Universitaire de Nīmes
Condition Anemia
Study Type INTERVENTIONAL
Enrollment 116 participants
Start Date 2023-11-09
Primary Completion 2027-05-30

Eligibility & Interventions

Sex All sexes
Min Age 60 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
transthoracic echocardiography

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 116 participants in total. It began in 2023-11-09 with a primary completion date of 2027-05-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this interventional study is to asses echocardiographic variations in emergency department's elderly patients receiving red blood cell transfusion. The main questions it aims to answer are : * is there a modification of echocardiographic parameters after red blood cell transfusion ? * which parameter is the most impacted by red blood cell transfusion ? Participants will have a transthoracic echocardiography before, just after and 15 minutes after red blood cell transfusion.

Eligibility Criteria

Inclusion Criteria: * patient needing red blood cell transfusion * consent * social protection Exclusion Criteria: * fluid filing over 500 mL of crystalloids * transfusion in the last hour

Frequently Asked Questions

Who can join the NCT06060639 clinical trial?

This trial is open to participants of all sexes, aged 60 Years or older, studying Anemia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06060639 currently recruiting?

Yes, NCT06060639 is actively recruiting participants. Visit ClinicalTrials.gov or contact Centre Hospitalier Universitaire de Nīmes to inquire about joining.

Where is the NCT06060639 trial being conducted?

This trial is being conducted at Nîmes, France.

Who is sponsoring the NCT06060639 clinical trial?

NCT06060639 is sponsored by Centre Hospitalier Universitaire de Nīmes. The trial plans to enroll 116 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology